136 related articles for article (PubMed ID: 3018695)
1. Actions of VIP, hGRF, PHI and secretin: comparative studies in cerebral cortex and adenohypophysis.
Magistretti PJ; Schönenberg P; Kehrer P; Martin JL; Gaillard RC
Peptides; 1986; 7 Suppl 1():175-80. PubMed ID: 3018695
[TBL] [Abstract][Full Text] [Related]
2. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
3. The effects of VIP on cyclic AMP and glycogen levels in vertebrate retina.
Schorderet M; Hof P; Magistretti PJ
Peptides; 1984; 5(2):295-8. PubMed ID: 6089132
[TBL] [Abstract][Full Text] [Related]
4. Effects of PACAP, VIP and related peptides on cyclic AMP formation in rat neuronal and astrocyte cultures and cerebral cortical slices.
Jozwiak-Bebenista M; Dejda A; Nowak JZ
Pharmacol Rep; 2007; 59(4):414-20. PubMed ID: 17901570
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
[TBL] [Abstract][Full Text] [Related]
6. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
7. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
[TBL] [Abstract][Full Text] [Related]
9. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
[TBL] [Abstract][Full Text] [Related]
10. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
11. Secretin stimulates cyclic AMP formation in the rat brain.
Fremeau RT; Korman LY; Moody TW
J Neurochem; 1986 Jun; 46(6):1947-55. PubMed ID: 3009718
[TBL] [Abstract][Full Text] [Related]
12. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of growth hormone release by vasoactive intestinal peptide and peptide PHI in rat anterior pituitary reaggregates. Permissive action of a glucocorticoid and inhibition by thyrotropin-releasing hormone.
Denef C; Schramme C; Baes M
Neuroendocrinology; 1985 Jan; 40(1):88-91. PubMed ID: 3918279
[TBL] [Abstract][Full Text] [Related]
14. The interactive effects of VIP, PHI, GHRH, and SRIF on the release of growth hormone from cultured adenohypophysial cells in cattle.
Soliman EB; Hashizume T; Ohashi S; Kanematsu S
Endocr J; 1995 Oct; 42(5):717-22. PubMed ID: 8574298
[TBL] [Abstract][Full Text] [Related]
15. Effects of neuropeptides of the secretin/VIP/PACAP family on cyclic AMP formation in the chick hypothalamus and cerebral cortex.
Nowak JZ; Kuba K; Zawilska JB
Pol J Pharmacol; 2000; 52(6):467-71. PubMed ID: 11334241
[TBL] [Abstract][Full Text] [Related]
16. Binding in vitro of vasoactive intestinal peptide on isolated acini of rat parotid glands.
Dehaye JP; Christophe J; Ernst F; Poloczek P; Van Bogaert P
Arch Oral Biol; 1985; 30(11-12):827-32. PubMed ID: 2421696
[TBL] [Abstract][Full Text] [Related]
17. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
Rekasi Z; Varga JL; Schally AV; Halmos G; Groot K; Czompoly T
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1218-23. PubMed ID: 10655511
[TBL] [Abstract][Full Text] [Related]
19. Interaction of thymic peptide thymosin alpha 1 with VIP receptors in rat intestinal epithelial cells: comparison with PHI and secretin.
Calvo JR; Guerrero JM; Goberna R
Gen Pharmacol; 1989; 20(4):503-5. PubMed ID: 2546855
[TBL] [Abstract][Full Text] [Related]
20. VIP receptor subtypes in mouse cerebral cortex: evidence for a differential localization in astrocytes, microvessels and synaptosomal membranes.
Martin JL; Feinstein DL; Yu N; Sorg O; Rossier C; Magistretti PJ
Brain Res; 1992 Jul; 587(1):1-12. PubMed ID: 1326373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]